Conditional Sox9 ablation reduces chondroitin sulfate proteoglycan levels and improves motor function following spinal cord injury
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Chondroitin sulfate proteoglycans (CSPGs) found in perineuronal nets and in the glial scar after spinal cord injury have been shown to inhibit axonal growth and plasticity. Since we have previously identified SOX9 as a transcription factor that upregulates the expression of a battery of genes associated with glial scar formation in primary astrocyte cultures, we predicted that conditional Sox9 ablation would result in reduced CSPG expression after spinal cord injury and that this would lead to increased neuroplasticity and improved locomotor recovery. Control and Sox9 conditional knock‐out mice were subject to a 70 kdyne contusion spinal cord injury at thoracic level 9. One week after injury, Sox9 conditional knock‐out mice expressed reduced levels of CSPG biosynthetic enzymes (Xt‐1 and C4st), CSPG core proteins (brevican, neurocan, and aggrecan), collagens 2a1 and 4a1, and Gfap, a marker of astrocyte activation, in the injured spinal cord compared with controls. These changes in gene expression were accompanied by improved hind limb function and locomotor recovery as evaluated by the Basso Mouse Scale (BMS) and rodent activity boxes. Histological assessments confirmed reduced CSPG deposition and collagenous scarring at the lesion of Sox9 conditional knock‐out mice, and demonstrated increased neurofilament‐positive fibers in the lesion penumbra and increased serotonin immunoreactivity caudal to the site of injury. These results suggest that SOX9 inhibition is a potential strategy for the treatment of SCI. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 1×
“Serotonergic projections synapsing in the dorsal horn modulate pain sensation (Bardin et al., 2000; Calejesan et al., 1998), serotonergic projections targeting sympathetic preganglionic neurons in the intermediolateral cell column (IML) contribute to autonomic regulation (Allen and Cechetto, 1994),…”
BackgroundAkiyama, H., Chaboissier, M.-C., Martin, J. F., Schedl, A., & de Crombrugghe, B. (2002) · Genes & Development · doi:10.1101/gad.1017802 · Cited by 1,721 · cited 2×
“We bred a mouse strain that carries floxed Sox9 (exons 2 and 3 of Sox9 surrounded by loxP sites) alleles (Akiyama et al., 2002) (Sox9) with a transgenic mouse line that expresses Cre recombinase fused to the mutated ligand binding domain of the human estrogen receptor (ER) under the control of a chimeric cytomegalovir…”
BackgroundSelf-citationReactivation of Ocular Dominance Plasticity in the Adult Visual Cortex
Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J. W., & Maffei, L. (2002) · Science · doi:10.1126/science.1072699 · Cited by 1,679
miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche
Cheng, L.-C., Pastrana, E., Tavazoie, M., & Doetsch, F. (2009) · Nature Neuroscience · doi:10.1038/nn.2294 · Cited by 1,001 · cited 1×
“MicroRNA studies also suggest that SOX9 is gliogenic, promoting neural stem cells to adopt an astrocyte or oligodendrocyte fate (Cheng et al., 2009).”
BackgroundLefebvre, V., Li, P., & de Crombrugghe, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5718 · Cited by 811
The bright side of the glial scar in CNS repair
Rolls, A., Shechter, R., & Schwartz, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2591 · Cited by 674 · cited 1×
“Although the glial scar plays a key role in the acute response to SCI by sealing the lesion site, restoring homeostasis, and modulating immunity, it also presents an obstacle to recovery by limiting structural plasticity (Rolls et al., 2009).”
BackgroundThe Sox9 transcription factor determines glial fate choice in the developing spinal cord
Stolt, C. C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl, A., & Wegner, M. (2003) · Genes & Development · doi:10.1101/gad.259003 · Cited by 636 · cited 4×
“Knocking out Sox9 in the developing mouse spinal cord results in perinatal lethality, decreased numbers of oligodendrocyte progenitors and astrocytes and an increased number of motor neurons (Stolt et al., 2003) and neuroblasts (Scott et al.”
BackgroundSelf-citationDavies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 2×
“…et al., 1998), and specific CSPGs that inhibit neurite outgrowth have been identified including: aggrecan (Condic et al., 1999), neurocan (Friedlander et al., 1994), phosphocan (Milev et al., 1994), brevican (Yamada et al., 1997), versican (Schmalfeldt et al., 2000), and NG2 (Dou and Levine, 1994).”
BackgroundGaltrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575 · cited 1×
“The combination of chondroitinase ABC with peripheral nerve grafts (Alilain et al., 2011; Houle et al., 2006), rehabilitation (Garcia-Alias et al., 2009; Wang et al., 2011), or neural precursor cell transplantation (Karimi-Abdolrezaee et al., 2010) have all led to improved axonal regeneration and…”
BackgroundWisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons
Härtig, W., Brauer, K., & Brückner, G. (1992) · NeuroReport · doi:10.1097/00001756-199210000-00012 · Cited by 440
Massey, J. M., Hubscher, C. H., Wagoner, M. R., Decker, J. A., Amps, J., Silver, J., & Onifer, S. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5467-05.2006 · Cited by 320 · cited 1×
“Evidence suggests that CSPGs are up-regulated within PNNs both near and far from a CNS lesion (Massey et al., 2006).”
BackgroundBrain derived versican V2 is a potent inhibitor of axonal growth
Schmalfeldt, M., Bandtlow, C. E., Dours-Zimmermann, M. T., Winterhalter, K. H., & Zimmermann, D. R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.5.807 · Cited by 197
Corvetti, L., & Rossi, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0683-05.2005 · Cited by 138
Cited by
Moving beyond the glial scar for spinal cord repair
Bradbury, E. J., & Burnside, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-11707-7 · Cited by 743
Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses
Orr, M. B., & Gensel, J. C. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0631-6 · Cited by 583
Hara, M., Kobayakawa, K., Ohkawa, Y., Kumamaru, H., Yokota, K., Saito, T., Kijima, K., Yoshizaki, S., Harimaya, K., Nakashima, Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4354 · Cited by 536
SOX9 Is an Astrocyte-Specific Nuclear Marker in the Adult Brain Outside the Neurogenic Regions
Sun, W., Cornwell, A., Li, J., Peng, S., Osorio, M. J., Aalling, N., Wang, S., Benraiss, A., Lou, N., Goldman, S. A., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3199-16.2017 · Cited by 357
“Consistent with this, it has been found recently that SOX9 is involved in the production of axon-prohibitive extracellular matrix after spinal cord injury and that conditional ablation of SOX9 expression improved functional recovery (McKillop et al., 2013).”
BackgroundResultAstrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
Cekanaviciute, E., & Buckwalter, M. S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0477-8 · Cited by 229
Metadata
- Authors
- McKillop, W. M., Dragan, M., Schedl, A., & Brown, A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2012-10
- Volume
- 61
- Issue
- 2
- Pages
- 164-177
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2009086604
- Cited by
- 86
- References
- 13
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.